Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1238391.RAXVzudLxxOtfF3F2RoZFL-t08U9HmF_hBa6pb07pCy1Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1238391.RAXVzudLxxOtfF3F2RoZFL-t08U9HmF_hBa6pb07pCy1Y130_assertion type Assertion NP1238391.RAXVzudLxxOtfF3F2RoZFL-t08U9HmF_hBa6pb07pCy1Y130_head.
- NP1238391.RAXVzudLxxOtfF3F2RoZFL-t08U9HmF_hBa6pb07pCy1Y130_assertion description "[366 breast cancer patients and 307 controls were genotyped for SNPs (n?=?41) in the F2, F3 (TF), F5, F7, F10, TFPI and EPCR genes, and assayed for plasma coagulation markers (thrombin generation, activated protein C (APC) resistance, D-dimer, antithrombin, protein C, protein S, and TF pathway inhibitor (TFPI)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238391.RAXVzudLxxOtfF3F2RoZFL-t08U9HmF_hBa6pb07pCy1Y130_provenance.
- NP1238391.RAXVzudLxxOtfF3F2RoZFL-t08U9HmF_hBa6pb07pCy1Y130_assertion evidence source_evidence_literature NP1238391.RAXVzudLxxOtfF3F2RoZFL-t08U9HmF_hBa6pb07pCy1Y130_provenance.
- NP1238391.RAXVzudLxxOtfF3F2RoZFL-t08U9HmF_hBa6pb07pCy1Y130_assertion SIO_000772 25407022 NP1238391.RAXVzudLxxOtfF3F2RoZFL-t08U9HmF_hBa6pb07pCy1Y130_provenance.
- NP1238391.RAXVzudLxxOtfF3F2RoZFL-t08U9HmF_hBa6pb07pCy1Y130_assertion wasDerivedFrom befree-2016 NP1238391.RAXVzudLxxOtfF3F2RoZFL-t08U9HmF_hBa6pb07pCy1Y130_provenance.
- NP1238391.RAXVzudLxxOtfF3F2RoZFL-t08U9HmF_hBa6pb07pCy1Y130_assertion wasGeneratedBy ECO_0000203 NP1238391.RAXVzudLxxOtfF3F2RoZFL-t08U9HmF_hBa6pb07pCy1Y130_provenance.